Xtant Medical Holdings Inc Share Price Today: Live Updates & Key Insights

Xtant Medical Holdings Inc share price today is $0.6037, up -3.72%. The stock opened at $0.627 against the previous close of $0.627, with an intraday high of $0.627 and low of $0.59.

Xtant Medical Holdings Inc Share Price Chart

Xtant Medical Holdings Inc

us-stock
To Invest in {{usstockname}}
us-stock

Xtant Medical Holdings Inc Share Price Performance

$0.6037 -0.0372(-3.72%) XTNT at 13 Mar 2026 03:58 PM Medical Devices
Lowest Today 0.59
Highest Today 0.627
Today’s Open 0.627
Prev. Close 0.627
52 Week High 0.95
52 Week Low 0.34
Day’s Range: Low 0.59 High 0.627
52-Week Range: Low 0.34 High 0.95
1 day return -
1 Week return +0.26
1 month return +1.8
3 month return -14.7
6 month return -4.33
1 year return +35.43
3 year return -8.69
5 year return -79.97
10 year return -

Xtant Medical Holdings Inc Institutional Holdings

Xtant Medical Holdings Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Xtant Medical Holdings Inc Fundamentals

Market Cap 87.78 M

PB Ratio 1.7423

PE Ratio 62.7

Enterprise Value 109.87 M

Total Assets 93.84 M

Volume 69837

Xtant Medical Holdings Inc Company Financials

Annual Revenue FY23:78465000 78.5M, FY22:57969000 58.0M, FY21:55263000 55.3M, FY20:53337000 53.3M, FY19:64682000 64.7M

Annual Profit FY23:46636000 46.6M, FY22:32137000 32.1M, FY21:32490000 32.5M, FY20:34392000 34.4M, FY19:42516000 42.5M

Annual Net worth FY23:2754000 2.8M, FY22:-8485000 -8.5M, FY21:-5844000 -5.8M, FY20:-7023000 -7.0M, FY19:-8221000 -8.2M

Quarterly Revenue Q3/2025:33255000 33.3M, Q2/2025:35411000 35.4M, Q1/2025:32904000 32.9M, Q3/2024:27937000 27.9M, Q2/2024:29943000 29.9M

Quarterly Profit Q3/2025:21992000 22.0M, Q2/2025:24284000 24.3M, Q1/2025:20243000 20.2M, Q3/2024:16307000 16.3M, Q2/2024:18582000 18.6M

Quarterly Net worth Q3/2025:1308000 1.3M, Q2/2025:3550000 3.6M, Q1/2025:58000 0.1M, Q3/2024:-5024000 -5.0M, Q2/2024:-3861000 -3.9M

About Xtant Medical Holdings Inc & investment objective

Company Information Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Organisation Medical Devices

Employees 217

Industry Medical Devices

CEO Mr. Sean E. Browne

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right